Antipsychotic drugs are increasingly being prescribed for children and adolescents, and are used in pregnant women without a clear demonstration of safety in these populations. Global effects of these drugs on neurodevelopment (e.g., decreased brain size) have been reported in rats, but detailed knowledge about neuronal effects and mechanisms of action are lacking. Here we report on the evaluation of a comprehensive panel of antipsychotic drugs in a model organism (Caenorhabditis elegans) that is widely used to study neuronal development. Specifically, we examined the effects of the drugs on neuronal migration and axonal outgrowth in mechanosensory neurons visualized with green fluorescent protein expressed from the mec-3 promoter. Clozapine, fluphenazine, and haloperidol produced deficits in the development and migration of ALM neurons and axonal outgrowth in PLM neurons. The defects included failure of neuroblasts to migrate to the proper location, and excessive growth of axons past their normal termination point, together with abnormal morphological features of the processes. Although the antipsychotic drugs are potent antagonists of dopamine and serotonin receptors, the neurodevelopmental deficits were not rescued by co-incubation with serotonin or the dopaminergic agonist, quinpirole. Other antipsychotic drugs, risperidone, aripiprazole, quetiapine, trifluoperazine and olanzapine, also produced modest, but detectable, effects on neuronal development. This is the first report that antipsychotic drugs interfere with neuronal migration and axonal outgrowth in a developing nervous system.
Introduction
Antipsychotic drugs are used to treat symptoms associated with several psychiatric illnesses including schizophrenia, bipolar disorder, and psychotic depression. Increasingly, these drugs are prescribed off label to adolescents and children as young as 2 years old (Findling et al., 1998; Zito et al., 2000) , and to pregnant women (Lanczik et al., 1998; Yaeger et al., 2006) . It is unclear whether early developmental exposure to antipsychotic drugs results in permanent changes in the brain that affect cognitive function or behavior later in life. Antipsychotic drugs have been reported to produce developmental deficits and neurological symptoms in humans. For example, in utero exposure to clozapine has been associated with floppy infant and jittery baby syndrome (Di Michele et al., 1996; Lanczik et al., 1998) , and lower developmental scores (Yoshida et al., 1998) . Moreover, it was recently reported that clozapine, but not haloperidol, produced long-lasting changes in the behavior of mice when given during gestation (Wang et al., 2006) . The FDA classifies antipsychotic drugs as class C because the risk of developmental defects cannot be excluded. More studies are needed to determine whether these drugs produce lasting adverse effects on the developing nervous system.
The neurotransmitters serotonin and dopamine play important roles during development of the nervous system. Serotonin acts as a trophic factor early in neurodevelopment, where it www.elsevier.com/locate/ijdevneu Int. J. Devl Neuroscience 26 (2008) 371-380
